Clinical Trials Directory

Trials / Completed

CompletedNCT03153761

CSD170201: A Study to Evaluate the Exposure to Tobacco Constituents From Two Moist Snuff Products

CSD170201: A Crossover Study to Evaluate the Exposure to Tobacco Constituents From Two Moist Snuff Products

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
53 (actual)
Sponsor
RAI Services Company · Industry
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

This study will evaluate exposure to tobacco constituents from two moist snuff products, and provide a basis for comparing mouth-level exposure (MLE) in moist snuff users after use of each of the two moist snuff products.

Detailed description

This will be an unblinded, single-center, randomized, two-way crossover study, conducted in generally healthy, adult moist snuff users who will be randomly assigned to the order in which they will use two moist snuff study products (comparator product, test product). Enrolled subjects will use one of each of the study products exclusively for approximately one week (seven days +1/-2 day) prior to a test visit, with a different product used each week over a two-week period. During each test visit, subjects will use study product ad libitum during a 6-hour period. Expectoration will be collected from the subjects during each product use. The used study product will be collected after use. Blood samples will be collected at each test visit, prior to study product use, for determination of plasma cotinine levels.

Conditions

Interventions

TypeNameDescription
OTHERCSD170201AAA moist snuff product
OTHERCSD170201ABA moist snuff product

Timeline

Start date
2017-05-08
Primary completion
2017-11-17
Completion
2017-11-17
First posted
2017-05-15
Last updated
2018-04-10

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03153761. Inclusion in this directory is not an endorsement.